Dear Maia,
In the message below, I see only the email of Kirvalidze…
Could you please provide me the full name?
Thank you!
Silviu
From: Tamar Gabunia
Sent: Thursday, May 14, 2020 12:07
To: DOMENTE, Silviu
Cc: Anzor tchavtchavadze
Subject: [EXT] RE: WEBINAR: Memo: WHO study visit to Swissmedic, 15-18 June 2020 in Bern, Switzerland - (Georgia)
Dear Silviu
Please kind below the list of participants for the upcoming webinar. All are senior staff members of the Regulatory Agency
Zaal Kapanadze, Director of the Regulatory Agency
zkapanadze@moh.gov.ge,
Kakha Shalikadze
kshalikadze@moh.gov.ge,
Gocha Aladashvili
galadashvili@moh.gov.ge,
Nana Shashiashvili
nshashiashvili@moh.gov.ge,
Naili Shengelia nshengelidze@moh.gov.ge,
I would like to suggest one alternate participant
Anzor Chavchavadze, Advisor at Health Policy Unit., MoLHSA CCed on this e-mail
With kind regards
Tamar
From: DOMENTE, Silviu [mailto:domentes@who.int]
Sent: 13 May, 2020 19:10
To: Tamar Gabunia <tgabunia@moh.gov.ge>
Subject: FW: WEBINAR: Memo: WHO study visit to Swissmedic, 15-18 June 2020 in Bern, Switzerland - (Georgia)
Dear Tamar,
WHO Headquarters were planning to organize a study visit for the NRA to Switzerland in June, and due to COVID-19 crisis it was initially cancelled.
However, the final decision is to still organize it virtually, and even increase the number of days and participants (see the correspondence below).
In this regard, I would like to ask you to nominate up to 6 participants for the Webinar to take place on 15-19 June, preferably from persons dealing with Marketing authorization, Pharmacovigilance and Quality management system.
Thank you and best regards,
Silviu
From: YAP, Maria Bernadette
Sent: Wednesday, May 13, 2020 2:58 PM
To: EURO WHO Office in Georgia <eurowhogeo@who.int>
Cc: GARNER, Sarah <garners@who.int>; POLISHCHUK, Olexandr <polishchuko@who.int>; PIRGARI, Dorina <pirgarid@who.int>; SILLO, Hiiti Baran
<silloh@who.int>; KHADEM BROOJERDI, Alireza <khadembroojerdia@who.int>; OSTAD ALI DEHAGHI, Razieh <ostadalidehaghir@who.int>; BROWN,
Laura Kay <brownl@who.int>
Subject: WEBINAR: Memo: WHO study visit to Swissmedic, 15-18 June 2020 in Bern, Switzerland - (Georgia)
On behalf of the Regulatory Systems Strengthening (RSS) Team, we would like to follow up with the attached memo and inform you that we have finally been able to organize this study visit as a virtual online course
using Webinar (it is not cancelled). This course will be conducted from 15 to 19 June 2020. Furthermore, this course is now enriched with more regulatory requirements to address current regulatory challenges to address COVID-19 pandemic. Please refer
to the attached updated Terms of Reference (TOR) for further information. The national regulatory authority (NRA) of Switzerland, represented by the Swiss Agency for Therapeutic Products (Swissmedic) in collaboration with the World Health Organization will
host this course. As the course will be conducted through Webinar, a maximum of six participants per NRA can be accommodated, instead of three. The weblink to join the
Webinar and relevant documentation and instructions will be shared with nominees before the course.
We would be very grateful if you would onforward the attached letter and updated TOR accordingly.
If you need additional information, please do not hesitate to contact Dr Razieh Ostad Ali Dehaghi,
ostadalidehaghir@who.int (responsible officer).
Best regards,
Ma. Bernadette Yap
On behalf of
Regulatory Systems Strengthening (RSS)
Regulation and Safety (REG)
Regulation and Prequalification (RPQ)
Web:
www.who.int
Follow WHO on
Facebook,
Twitter,
YouTube,
Instagram
From: YAP, Maria Bernadette
Sent: Monday, April 6, 2020 5:28 PM
To: EURO WHO Office in Georgia <eurowhogeo@who.int>
Cc: GARNER, Sarah <garners@who.int>; POLISHCHUK, Olexandr <polishchuko@who.int>; PIRGARI, Dorina <pirgarid@who.int>; SILLO, Hiiti Baran
(silloh@who.int) <silloh@who.int>; KHADEM BROOJERDI, Alireza <khadembroojerdia@who.int>; OSTAD ALI DEHAGHI, Razieh <ostadalidehaghir@who.int>;
BROWN, Laura Kay <brownl@who.int>
Subject: CANCELLED: RE: Memo: WHO study visit to Swissmedic, 15-18 June 2020 in Bern, Switzerland - (Georgia)
In view of the current and progressing situation of the Covid-19, we kindly inform that the planned WHO study visit to Swissmedic,
from 15 to 18 June 2020 in Bern, Switzerland
has been cancelled.
On behalf of
Regulatory Systems Strengthening (RSS)
Regulation and Safety (REG)
Regulation and Prequalification (RPQ)
Web:
www.who.int
Follow WHO on
Facebook,
Twitter,
YouTube,
Instagram
From: YAP, Maria Bernadette
Sent: Friday, April 3, 2020 4:46 PM
To: EURO WHO Office in Georgia <eurowhogeo@who.int>
Cc: GARNER, Sarah <garners@who.int>; POLISHCHUK, Olexandr <polishchuko@who.int>; PIRGARI, Dorina <pirgarid@who.int>; SILLO, Hiiti Baran
(silloh@who.int) <silloh@who.int>; KHADEM BROOJERDI, Alireza <khadembroojerdia@who.int>; OSTAD ALI DEHAGHI, Razieh <ostadalidehaghir@who.int>;
BROWN, Laura Kay <brownl@who.int>
Subject: Memo: WHO study visit to Swissmedic, 15-18 June 2020 in Bern, Switzerland - (Georgia)
On behalf of the Regulatory Systems Strengthening (RSS) Team, please find attached memo regarding the planned WHO study visit to the Swiss Agency for Therapeutic Products (Swissmedic), from 15 to
18 June 2020, to be held in Bern, Switzerland. Please see attached draft terms of reference (TOR).
If you are in agreement with this proposal, we would be grateful if your office would forward the attached invitation letter and attachments to the Agency of Medical and Pharmaceutical Activities and facilitate
the nomination and participation of the representatives in this WHO study visit to Swissmedic.
If you would like further technical information, please do not hesitate to contact
Dr Razieh Ostad Ali Dehaghi,
ostadalidehaghir@who.int (responsible officer).
We thank you very much for your kind collaboration.
Kind regards,
Ma. Bernadette Yap
Regulatory Systems Strengthening (RSS)
Regulation and Safety (REG)
Regulation and Prequalification (RPQ)
Office: +41 (0)22 791 3750
Fax: +41 (0)22 791 4856
Web:
www.who.int
Follow WHO on
Facebook,
Twitter,
YouTube,
Instagram